UnitedHealth Stock: Is the Market Overreacting to Lower-Than-Expected Medicare Rates?

Core Viewpoint - UnitedHealth Group's stock has been declining sharply following disappointing earnings, raising concerns about its future growth potential, particularly in light of proposed Medicare changes [1][3]. Financial Performance - In 2025, UnitedHealth reported full-year revenue of $447.6 billion, a 12% increase from the previous year, with the Medicare & retirement segment growing by approximately 23% to $171.3 billion, representing over 38% of total revenue [2]. - The Medicare & retirement segment has seen an 89% increase in revenue since 2020, when it was $90.8 billion [2]. Future Outlook - The company is anticipating a challenging year in 2026, projecting revenue to decline to around $439 billion, a decrease of 2% [4]. - Concerns are heightened by the Trump administration's proposal to keep Medicare Advantage rates flat in 2027, which could significantly impact UnitedHealth's business [3][4]. Valuation Concerns - If UnitedHealth transitions to being viewed primarily as a dividend stock, currently yielding 3.2%, its valuation may decrease, leading to a lower earnings multiple [5]. - The stock is currently trading at a price-to-earnings multiple of 14, but without expected growth, justifying a higher price may become difficult [5].